Finally, after four months without Internet, power, and water, things are slowly going back to normality here in PR. Nice to be back to share a lot of new tools, miners, research tutorials we were working on during the forced vacations.
The Docker miner is our newest Minerazzi miner, available now at
Find Docker development resources, news, & more.
The news sections includes channels to Bing, Google and several blogs relevant to Docker and its container technology.
The Azure miner is available now at
It can help you to find Microsoft Azure public resources, news, and more. Recrawling search result pages allows you to build your own curated collection. Be productive with the Azure miner.
In addition, the news section includes relevant search, blog, and community channels.
Happy Azure day! 🙂
We have two new Minerazzi miners, AWS and AI, available now at
Use this miner to easily find Amazon Web Services public resources, news, and more.
Use this miner to quickly find artificial intelligence resources, tutorials, news, and more.
On a side note, here is a little challenge for you. Can you decipher the following string?
iii teen cell fractal gini
The solution is quite obvious.
This is a new miner available now at
Find resources relevant to meta-analysis, effect sizes, and power analysis with this Minerazzi miner.
Build curated collections on these subjects.
The miner includes Bing and Google RSS News channels powered by our SPP tool.
This is a new Minerazzi miner that is available now at
Find business, research, technology, legal resources, and more relevant to medical cannabis.
Talking about the subject, according to a CNBC news at
“Oxford University will be at the forefront of a multimillion-pound research program, which hopes to help develop new therapies for acute and chronic conditions by examining the effects of medical cannabis. ”
“The oldest university in England will be teaming up with private equity company, Kingsley Capital Partners who will provide up to £10 million ($12.36 million) in initial investment, which will be funded through its new biopharmaceutical firm Oxford Cannabinoid Technologies (OCT). ”
“The partnership is expected to bring together Kingsley’s financial backing and Oxford’s clinical expertise and research in immunology, neuroscience and cancer, to find ways of developing new treatments for those suffering with pain, cancer and inflammatory disease. ”
“Scientists at the university expect to do this by studying the cellular, molecular, and systems mechanisms of cannabinoids. ”